GLP-1 Medication Use for Type 2 Diabetes Has Soared
JAMA · 24.09.2024 · 332 (12) · 952
DOI: 10.1001/jama.2024.18219 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 24.09.2024. Verfasst von Thomas A Hegland und 2 weiteren Autor:innen. Beteiligte Einrichtung: Economist, Division of Research and Modelling, Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor Agonists, Drug Prescriptions. Die Arbeit wurde bisher 51-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
This JAMA Data Brief discusses new data from the Medical Expenditure Panel Survey, or MEPS, Household Component, a household survey sponsored by the Agency for Healthcare Research and Quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Economist, Division of Research and Modelling, Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality.
- Survey Statistician, Office of the Director, Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality.
- Manager and Senior Medical Illustrator, Editorial Graphics, JAMA and JAMA Network.
Zitieren
APA
Hegland, T. A., Fang, Z., & Bucher, K. (2024). GLP-1 Medication Use for Type 2 Diabetes Has Soared. JAMA, 332(12), 952. https://doi.org/10.1001/jama.2024.18219
Vancouver
Hegland TA, Fang Z, Bucher K. GLP-1 Medication Use for Type 2 Diabetes Has Soared. JAMA. 2024;332(12):952. doi:10.1001/jama.2024.18219
BibTeX
@article{Hegland2024,
author = {Hegland, Thomas A and Fang, Zhengyi and Bucher, Karen},
title = {GLP-1 Medication Use for Type 2 Diabetes Has Soared},
journal = {JAMA},
year = {2024},
volume = {332},
number = {12},
pages = {952},
doi = {10.1001/jama.2024.18219}
}
EUVIMED